These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4740286)

  • 1. Oral absorption of commercial buffered aspirin tablets.
    Chiou WL; Onyemelukwe I
    JAMA; 1973 Jul; 225(2):177-8. PubMed ID: 4740286
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of activated charcoal on aspirin absorption in man. Part I.
    Levy G; Tsuchiya T
    Clin Pharmacol Ther; 1972; 13(3):317-22. PubMed ID: 5026372
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of aspirin, salicylic acid, and salicyluric acid following oral administration of aspirin as a tablet and two buffered solutions.
    Mason WD; Winer N
    J Pharm Sci; 1981 Mar; 70(3):262-5. PubMed ID: 7264888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state salicylate plasma and urinary metabolite concentrations from plain, buffered, or enteric-coated aspirin.
    Allen JH; Thakker KM; Small RE; Wood JH; Willis HE
    Clin Pharm; 1983; 2(1):64-6. PubMed ID: 6883933
    [No Abstract]   [Full Text] [Related]  

  • 5. [Absorption studies on salicylates. 1. Absorption of acetylsalicylic acid after oral application].
    Pütter J; Bauer K
    Arzneimittelforschung; 1970 Nov; 20(11):1718-20. PubMed ID: 5536978
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of food on aspirin absorption from tablets and buffered solutions.
    Mason WD; Winer N
    J Pharm Sci; 1983 Jul; 72(7):819-21. PubMed ID: 6886992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal absorption from aspirin suppositories in children and adults.
    Nowak MM; Brundhofer B; Gibaldi M
    Pediatrics; 1974 Jul; 54(1):23-6. PubMed ID: 4834297
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of salicylic acid following administration of aspirin tablets and three different forms of soluble aspirin in normal subjects.
    Gatti G; Barzaghi N; Attardo Parrinello G; Vitiello B; Perucca E
    Int J Clin Pharmacol Res; 1989; 9(6):385-9. PubMed ID: 2517497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
    Paton TW; Walker SE; Leung FY; Little AH
    Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946
    [No Abstract]   [Full Text] [Related]  

  • 10. The bioavailability of enteric-coated acetylsalicylic acid: a comparison with buffered ASA in rheumatoid arthritis II.
    Canada AT; Little AH; Creighton EL
    Curr Ther Res Clin Exp; 1976 May; 19(5):554-7. PubMed ID: 820521
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability studies on a buffered acetylsalicylic acid preparation.
    Ekenved G; Elofsson R; Sölvell L
    Acta Pharm Suec; 1975; 12(4):323-32. PubMed ID: 1106118
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of physiological availability of aspirin tablets.
    Corrigan OI; Timoney RF
    Ir J Med Sci; 1970 Jan; 3(1):15-21. PubMed ID: 5444547
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative bioavailability of aspirin gum.
    Woodford DW; Lesko LJ
    J Pharm Sci; 1981 Dec; 70(12):1341-3. PubMed ID: 7320849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified USP assay for simultaneous determination of aspirin and nonaspirin salicylates in aspirin and buffered aspirin tablets.
    Luber JR; Visalli AJ; Patel DM
    J Pharm Sci; 1979 Jun; 68(6):780-2. PubMed ID: 458583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
    Scholtz EC; Jaffe JM; Colaizzi JL
    Am J Hosp Pharm; 1978 Nov; 35(11):1355-9. PubMed ID: 707504
    [No Abstract]   [Full Text] [Related]  

  • 17. Disintegration, dissolution, oral absorption in humans of five commercial buffered aspirin dosage forms.
    Chiou WL; Onyemelukwe I
    J Clin Pharmacol; 1974; 14(11-12):597-603. PubMed ID: 4436446
    [No Abstract]   [Full Text] [Related]  

  • 18. Absorption, and effect on gastric mucosa, of buffered and non-buffered tablets of acetylsalicylic acid.
    Linnoila M; Lehtola J
    Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):61-4. PubMed ID: 885664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biopharmaceutical evaluation of some tablets of acetylsalicylic acid. Importance of the method of dissolution in the establishment of the in vivo and in vitro correlations].
    Doelker E; Schwyter H; Mordier D
    Pharm Acta Helv; 1975; 50(1-2):24-7. PubMed ID: 1114158
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetics of aspirin absorption following oral administration of six aqueous solutions with different buffer capacities.
    Mason WD
    J Pharm Sci; 1984 Sep; 73(9):1258-61. PubMed ID: 6491946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.